RemedyCraft RSS https://remedycraft.com/ Clinical updates and evidence-based guides Tue, 09 Sep 2025 18:13:06 +0000 Phase III trial improves overall survival in lung cancer https://remedycraft.com/news/clinical-trial-lung-cancer-os/ Tue, 09 Sep 2025 18:13:06 +0000 Randomized phase III trial shows improved OS with an immunotherapy combination. FDA authorizes next-gen CGM https://remedycraft.com/news/fda-approves-new-cgm/ Tue, 09 Sep 2025 18:13:06 +0000 Over-the-counter CGM aims to broaden access with education needs.